Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/26/18 → 6/30/20 |
Funding
- Tetraphase Pharmaceuticals Incorporated: $13,020.00
Activity of Eravacycline Against Carbapenem-resistant Enterobacteriaceae
- Burgess, David (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 11/26/18 → 6/30/20 |